Lipase Reagent Market Trends

  • Report ID: 4247
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Lipase Reagent Market Trends

Growth Drivers

  • Increasing Diarrhea Cases in Children- Globally, 1.7 billion children are affected with diarrhea disease every year according to the World Health Organization.
  • Rising Concern for Diagnosis – The accurate detection of several medical disorders that might be suggested by increased levels of lipase in the body is a rising issue. For these kinds of illnesses to be effectively treated and managed, a fast and accurate diagnosis is crucial. The primary diagnosis at office visits for all digestive diseases was stated to be 36.6 million in the year 2010 in the U.S.
  • Government Initiatives in the Healthcare Sector –The Universal Health Coverage progress rate is projected to cover health services to 290 million by 2023, compared to the baseline value of 2018 leaving a difference of 710 million to reach the target.
  • Poor Lifestyle and Nutritional Deficiency – Elevated lipase levels and other metabolic abnormalities can be caused by a poor lifestyle and dietary deficits.  As per the Food and Agriculture Organization of the United Nations, it is estimated that between 720 to 811 million individuals faced hunger worldwide in 2020.
  • Lack of Sanitation Knowledge and the Unhygienic Environment– As of 2021 among 3.6 billion people, only 1.9 billion people are living with basic sanitation services and 494 million go for open defecation. Moreover, the population growth is also leading to higher demand for sanitation services, which is further anticipated to boost the market growth. The world population raised from about 1 billion in 1800 to 7.9 billion in 2019.

Challenges

  • Lack of Proper Healthcare System in Low-Income Regions
  • Less Awareness of the Diagnosis and Gastric Issues
  • High Treatment Cost – When medical disorders that are indicated by higher lipase levels are treated, the costs might be significant, particularly if hospitalization, operation, or long-term medication is necessary. In 2019, one-fourth, about 26% of U.S. adults reported that they had a problem paying medical bills, 2018.

Lipase Reagent Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~7%

Base Year Market Size (2022)

~ USD 631 Billion

Forecast Year Market Size (2035)

~ USD 1521 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

6.9%

Base Year Market Size (2024)

USD 721.08 billion

Forecast Year Market Size (2037)

USD 1.71 trillion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4247
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of lipase reagent is estimated at USD 802.88 billion.

The lipase reagent market size was valued at USD 721.08 billion in 2024 and is likely to cross USD 1.71 trillion by 2037, expanding at more than 6.9% CAGR during the forecast period i.e., between 2025-2037. Increasing gastrointestinal issues and rising concern for diagnosis will boost the market growth.

North America industry is set to hold largest revenue share of 36% by 2037, on the back of increasing concern among people about complications related to gastrointestinal tract.

The major players in the market are DIALAB, DiaSys Diagnostic Systems GmbH, Sunson Industry Group Co., Ltd, Randox Laboratories Ltd., Abbott, Beckman Coulter, Inc., Biocompare, VitroScient, Merck Group, Sisco Research Laboratories Pvt. Ltd., BioSystems
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample